These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3092906)

  • 21. [Diagnosis and treatment of acute intermittent porphyria].
    Karazhanova LK; Ualieva TM
    Klin Med (Mosk); 1991 Sep; 69(9):82. PubMed ID: 1803165
    [No Abstract]   [Full Text] [Related]  

  • 22. [Uses of silymarin in the treatment of symptomatic hepatic porphyria (author's transl)].
    Kordac V; Kaláb M
    Cas Lek Cesk; 1977 Apr; 116(13):407-10. PubMed ID: 861998
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment with haematin in acute hepatic porphyria.
    McColl KE; Moore MR; Thompson GG; Goldberg A
    Q J Med; 1981; 50(198):161-74. PubMed ID: 7302116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [2 years' experience with the treatment of symptomatic liver porphyria with pyrimethamine].
    Cervinka J; Kaláb M; Martásek P; Kotal P; Marecek Z; Jirsa M; Kordac V; Soldátová H
    Cas Lek Cesk; 1985 Aug; 124(35):1107-12. PubMed ID: 4028097
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of pyrimethamine on clinical and biochemical manifestations of symptomatic liver porphyria].
    Cervinka J; Kaláb M; Kordac V; Jirsa M; Martásek P; Papezová R
    Cas Lek Cesk; 1983 Apr; 122(16):487-90. PubMed ID: 6616532
    [No Abstract]   [Full Text] [Related]  

  • 26. Optical and EPR spectroscopy studies on haem arginate, a new compound used for treatment of porphyria.
    Sievers G; Häkli H; Luhtala J; Tenhunen R
    Chem Biol Interact; 1987; 63(2):105-14. PubMed ID: 2822264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis and traditional Chinese medicine combined with Western medicine in the treatment of hepatic porphyria].
    Chen MH
    Zhong Xi Yi Jie He Za Zhi; 1988 Sep; 8(9):573-5. PubMed ID: 3073878
    [No Abstract]   [Full Text] [Related]  

  • 28. Porphyria and pain management.
    Morse RH
    J La State Med Soc; 1984 Aug; 136(8):15-6, 18. PubMed ID: 6152284
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience with the therapy of symptomatic liver porphyria using a combination of antimalarial agents--chloroquine with pyrimethamine].
    Zoubek V; Martásek P; Kordac V
    Cas Lek Cesk; 1987 Feb; 126(6):170-3. PubMed ID: 3815471
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of acute intermittent porphyria. The first use of Heme-arginate in Czechoslovakia].
    Kordac V; Martásek P
    Cas Lek Cesk; 1987 Jul; 126(30):944-7. PubMed ID: 3652151
    [No Abstract]   [Full Text] [Related]  

  • 31. [2 years' experience with combined therapy of symptomatic liver porphyria using pyrimethamine and chloroquine].
    Kaláb M; Cervinka J; Kotal P; Jirsa M; Kordac V; Marecek Z; Soldátová H; Papezová P
    Cas Lek Cesk; 1988 Mar; 127(10):305-9. PubMed ID: 3365727
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemin treatment in a case of porphyria variegata].
    Adam C; Hassoun A; Defresne C; Guilmot-Bruneau M; Wery-Follet B; Saussez-De Temmerman A
    Dermatologica; 1982; 165(6):640-6. PubMed ID: 7169140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The liver in protoporphyria.
    Bloomer JR
    Hepatology; 1988; 8(2):402-7. PubMed ID: 3281889
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
    Kordac V; Martásek P; Kaláb M; Semrádová M; Papezová R
    Cas Lek Cesk; 1981 Oct; 120(40):1225-7. PubMed ID: 7344792
    [No Abstract]   [Full Text] [Related]  

  • 35. [Suburoporphyrins in symptomatic hepatic porphyria and in experimental porphyria (author's transl)].
    Kaláb M; Jirsa M; Kordac V; Soldátová H
    Cas Lek Cesk; 1981 Oct; 120(41):1251-4. PubMed ID: 7344798
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term treatment of porphyria cutanea tarda with low chloroquine doses.
    Holvay E
    Ther Hung; 1981; 29(1):42-6. PubMed ID: 7188240
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of acute porphyrias. The importance of follow-up of patients and carriers].
    Tasnádi G; Bor M; Pusztai A
    Orv Hetil; 2003 May; 144(19):933-8. PubMed ID: 12809070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term therapy of liver diseases].
    Markoff N
    Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathobiochemistry of porphyrias].
    Doss M
    Med Klin; 1977 Sep; 72(38):1501-18. PubMed ID: 333255
    [No Abstract]   [Full Text] [Related]  

  • 40. Tryptophan pyrrolase, the regulatory free haem and hepatic porphyrias. Early depletion of haem by clinical and experimental exacerbators of porphyria.
    Badawy AA
    Biochem J; 1978 Jun; 172(3):487-94. PubMed ID: 687356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.